Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681042 · ClinicalTrials.gov registry record · NA
Left Atrial Appendage Closure With SentreHeart Lariat® Device
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02681042 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 9 participants.
The verdict
NCT02681042, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy is favorable for placement of the Lariat® device, the procedure will be performed at one of the participating centers. If anatomy is not favorable, the patient will be excluded from the study and managed using best care practices by his or her physician.
Interventions
- PROCEDURE Left atrial appendage closure
- DEVICE SentreHeart Lariat®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681042
The ClinicalTrials.gov registry entry for NCT02681042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Left atrial appendage closure is the first listed.
NCT02681042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681042 about?
NCT02681042 is a clinical study titled "Left Atrial Appendage Closure With SentreHeart Lariat® Device". The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy i...
What is the current status of trial NCT02681042?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-03. Estimated completion is 2018-05-02.
What interventions are being tested in trial NCT02681042?
The interventions under investigation include: Left atrial appendage closure (PROCEDURE), SentreHeart Lariat® (DEVICE).
Who is sponsoring clinical trial NCT02681042?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.